Invention Grant
US09045475B2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
有权
凋亡诱导剂用于治疗癌症和免疫和自身免疫性疾病
- Patent Title: Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
- Patent Title (中): 凋亡诱导剂用于治疗癌症和免疫和自身免疫性疾病
-
Application No.: US13830926Application Date: 2013-03-14
-
Publication No.: US09045475B2Publication Date: 2015-06-02
- Inventor: Steven W. Elmore , Andrew J. Souers , Zhi-Fu Tao
- Applicant: AbbVie Inc. , Genentech, Inc. , The Walter and Eliza Institute of Medical Research
- Applicant Address: US IL North Chicago US CA South San Francisco AU Parkville
- Assignee: ABBVIE INC.,GENENTECH, INC.,THE WALTER AND ELIZA INSTITUTE OF MEDICAL RESEARCH
- Current Assignee: ABBVIE INC.,GENENTECH, INC.,THE WALTER AND ELIZA INSTITUTE OF MEDICAL RESEARCH
- Current Assignee Address: US IL North Chicago US CA South San Francisco AU Parkville
- Agency: Jones Day
- Main IPC: A61K31/407
- IPC: A61K31/407 ; C07D401/12 ; C07D471/04 ; C07D401/14 ; C07D519/00 ; C07D209/82 ; C07D403/12 ; A61K31/496
Abstract:
Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
Public/Granted literature
- US20130267534A1 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES Public/Granted day:2013-10-10
Information query
IPC分类:
